✅ Expanded Steering Committee ✅ Expanded Advisory/Support Group ✅ Clarified version tracking section ✅ Randomization procedure clarified to be performed using sealed envelopes instead of a digital randomization system ✅ Specified that neuroprognostication is not required for participants who are awake at 72 hours ✅ Minor editorial and formatting revisions throughout the document
✅ Co-PI formatted. ✅ Minor administrative and formatting updates to the cover page and document layout (version formatting, spacing and typography). ✅ No changes to study design, eligibility criteria, interventions, endpoints, procedures, statistical methods or safety assessments.
✅ ClinicalTrials.gov registration added ✅ Expanded Steering Committee ✅ Expanded Advisory/Support group ✅ Upper age limit changed from 80 years to 79 years ✅ Planned sample size increased from 924 to 1022 participants to account for one interim analysis. Sample size including estimated loss to follow-up. ✅ Statistical section clarified and expanded, including: ⟢ description of a pilot/interim phase ⟢ clearer description of safety monitoring ✅ Minor editorial and structural revisions throughout the documentÂ